Back to Search Start Over

Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel.

Authors :
Nekrasova OV
Volyntseva AD
Kudryashova KS
Novoseletsky VN
Lyapina EA
Illarionova AV
Yakimov SA
Korolkova YV
Shaitan KV
Kirpichnikov MP
Feofanov AV
Source :
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology [J Neuroimmune Pharmacol] 2017 Jun; Vol. 12 (2), pp. 260-276. Date of Electronic Publication: 2016 Sep 17.
Publication Year :
2017

Abstract

Potassium voltage-gated Kv1.6 channel, which is distributed primarily in neurons of central and peripheral nervous systems, is of significant physiological importance. To date, several high-affinity Kv1.6-channel blockers are known, but the lack of selective ones among them hampers the studies of tissue localization and functioning of Kv1.6 channels. Here we present an approach to advanced understanding of interactions of peptide toxin blockers with a Kv1.6 pore. It combines molecular modeling studies and an application of a new bioengineering system based on a KcsA-Kv1.6 hybrid channel for the quantitative fluorescent analysis of blocker-channel interactions. Using this system we demonstrate that peptide toxins agitoxin 2, kaliotoxin1 and OSK1 have similar high affinity to the extracellular vestibule of the K <superscript>+</superscript> -conducting pore of Kv1.6, hetlaxin is a low-affinity ligand, whereas margatoxin and scyllatoxin do not bind to Kv1.6 pore. Binding of toxins to Kv1.6 pore has considerable inverse dependence on the ionic strength. Model structures of KcsA-Kv1.6 and Kv1.6 complexes with agitoxin 2, kaliotoxin 1 and OSK1 were obtained using homology modeling and molecular dynamics simulation. Interaction interfaces, which are formed by 15-19 toxin residues and 10 channel residues, are described and compared. Specific sites of Kv1.6 pore recognition are identified for targeting of peptide blockers. Analysis of interactions between agitoxin 2 derivatives with point mutations (S7K, S11G, L19S, R31G) and KcsA-Kv1.6 confirms reliability of the calculated complex structure.

Details

Language :
English
ISSN :
1557-1904
Volume :
12
Issue :
2
Database :
MEDLINE
Journal :
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Publication Type :
Academic Journal
Accession number :
27640211
Full Text :
https://doi.org/10.1007/s11481-016-9710-9